nach oben

Erschienen in:

30.07.2014 | Zertifizierte Fortbildung

Akute bakterielle Meningitis — Diagnostik und Therapie

Infektionserkrankungen in der Neurologie

verfasst von: PD Dr. med. Matthias Klein, Prof. Dr. med. Hans-Walter Klein

Erschienen in: DNP – Die Neurologie & Psychiatrie | Ausgabe 7-8/2014

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die akute bakterielle Meningitis ist ein neurologischer Notfall und erfordert eine umgehende Diagnostik einschließlich Liquorpunktion. Wichtig für eine optimale Behandlung sind neben der diagnostischen Sicherung vor allem eine schnelle und kalkulierte empirische antibiotische Therapie sowie ein frühzeitiges Erkennen und Behandeln von intrakraniellen und systemischen Komplikationen.

Brouwer MC, Heckenberg SG, de Gans J, Spanjaard L, Reitsma JB, van de Beek D. Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology 2010 Oct 26;75(17):1533–9.PubMedCrossRef

RKI. Aktuelle Statistik meldepfiichtiger Infektionskrankheiten, Deutschland. Epidemiologisches Bulletin 3, 31. 2014.

RKI. Meningokokken, invasive Erkrankungen. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2012, 150–155. 1-3-2013.

RKI. Invasive Meningokokken-Erkrankungen: retrospektive Erhebung von Verdachtsmeldungen. Epidemiologisches Bulletin 2009; 8. 2009.

RKI. Aktuelle Statistik meldepflichtiger Infektionskrankheiten. Epidemiologisches Bulletin 2009; 20. 2009.

DGPI (Deutsche Gesellschaft für Pädiatrische Infektiologie). Meningitis. Futuramed Verlag, München 2009.

Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain 2003 May;126(Pt 5):1015–25.PubMedCrossRef

van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004 Nov 28;351(18):1849–59.PubMedCrossRef

Heckenberg SG, de Gans J, Brouwer MC, Weisfelt M, Piet JR, Spanjaard L, et al. Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine (Baltimore) 2008 Jul;87(4):185–92.CrossRef

10.

Hasbun R, Abrahams J, Jekel J, Quagliarello VJ. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 2001 Dec 13;345(24):1727–33.PubMedCrossRef

11.

Joffe AR. Lumbar puncture and brain herniation in acute bacterial meningitis: a review. J Intensive Care Med 2007 Jul;22(4):194–207.PubMedCrossRef

12.

Brouwer MC, Thwaites GE, Tunkel AR, van de BD. Dilemmas in the diagnosis of acute community-acquired bacterial meningitis. Lancet 2012 Nov 10;380(9854):1684–92.PubMedCrossRef

13.

Pfister HW, Bühler R, Eiffert H, Nau R, Weber JR. Ambulant erworbene bakterielle (eitrige) Meningitis. Leitlinien für Diagnostik und Therapie in der Neurologie der DGN. 494-504. 2012. Thieme Verlag.

14.

Koster-Rasmussen R, Korshin A, Meyer CN. Antibiotic treatment delay and outcome in acute bacterial meningitis. J Infect 2008 Dec;57(6):449–54.PubMedCrossRef

15.

Auburtin M, Wolff M, Charpentier J, Varon E, Le TY, Girault C, et al. Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit Care Med 2006 Nov;34(11):2758–65.PubMedCrossRef

16.

Klein M, Pfister HW, Leib SL, Koedel U. Therapy of community-acquired acute bacterial meningitis: the clock is running. Expert Opin Pharmacother 2009 Nov;10(16):2609–23.PubMedCrossRef

17.

Klein M, Pfister HW. [Bacterial infections of the central nervous system]. Nervenarzt 2010 Feb;81(2):150–61.PubMedCrossRef

18.

Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS, Jr., et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993 Jan 7;328(1):21–8.PubMedCrossRef

19.

Nigrovic LE, Malley R, Macias CG, Kanegaye JT, Moro-Sutherland DM, Schremmer RD, et al. Effect of antibiotic pretreatment on cerebrospinal fluid profiles of children with bacterial meningitis. Pediatrics 2008 Oct;122(4):726–30.

20.

Tamune H, Takeya H, Suzuki W, Tagashira Y, Kuki T, Honda H, et al. Cerebrospinal fluid/ blood glucose ratio as an indicator for bacterial meningitis. Am J Emerg Med 2013 Nov 26(13):10.

21.

Sakushima K, Hayashino Y, Kawaguchi T, Jackson JL, Fukuhara S. Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis: a meta-analysis. J Infect 2011 Apr;62(4):255–62.PubMedCrossRef

22.

Nathan BR, Scheld WM. The potential roles of C-reactive protein and procalcitonin concentrations in the serum and cerebrospinal fluid in the diagnosis of bacterial meningitis. Curr Clin Top Infect Dis 2002;22:155–65.PubMed

23.

Schwarz S, Bertram M, Schwab S, Andrassy K, Hacke W. Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med 2000 Jun;28(6):1828–32.PubMedCrossRef

24.

Dubos F, Moulin F, Gajdos V, De SN, Biscardi S, Lebon P, et al. Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis. J Pediatr 2006 Jul;149(1):72–6.PubMedCrossRef

25.

Dubos F, Korczowski B, Aygun DA, Martinot A, Prat C, Galetto-Lacour A, et al. Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: a European multicenter case cohort study. Arch Pediatr Adolesc Med 2008 Dec;162(12):1157–63.PubMedCrossRef

26.

Krysan D. Serum procalcitonin levels aid in distinguishing bacterial from aseptic meningitis in children. J Pediatr 2009 May;154(5):773.PubMedCrossRef

27.

Viallon A, Desseigne N, Marjollet O, Birynczyk A, Belin M, Guyomarch S, et al. Meningitis in adult patients with a negative direct cerebrospinal fluid examination: value of cytochemical markers for differential diagnosis. Crit Care 2011 Jun 6;15(3):R136.PubMedCentralPubMedCrossRef

28.

Chaudhuri A, Martin PM, Kennedy PG, Andrew SR, Portegies P, Bojar M, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol 2008 Jul;15(7):649–59.PubMedCrossRef

29.

Imohl M, Reinert RR, van der LM. New penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effects on susceptibility categorisation in Germany (1992-2008). Int J Antimicrob Agents 2009 May 4.

30.

Imohl M, Reinert RR, van der LM. Serotypespecific penicillin resistance of Streptococcus pneumoniae in Germany from 1992 to 2008. Int J Med Microbiol 2010 Jun;300(5):324–30.PubMedCrossRef

31.

van de Beek D, Brouwer MC, Thwaites GE, Tunkel AR. Advances in treatment of bacterial meningitis. Lancet 2012 Nov 10;380(9854):1693–702.PubMedCrossRef

32.

Jenkins SG, Brown SD, Farrell DJ. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4. Ann Clin Microbiol Antimicrob 2008 Jan 11;7:1.CrossRef

33.

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Beekmann SE, Doern GV. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005. Clin Infect Dis 2009 Feb 1;2009:e23–e33.CrossRef

34.

Reinert R, Reinert S, van der Linden M, Cil MY, Al-Lahham A, Appelbaum P. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Antimicrob Agents Chemother 2005 Jul;49(7):2903–13.PubMedCentralPubMedCrossRef

35.

Rupprecht TA, Pfister HW. Clinical experience with linezolid for the treatment of central nervous system infections. Eur J Neurol 2005 Jul;12(7):536–42.PubMedCrossRef

36.

Ntziora F, Falagas ME. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother 2007 Feb;41(2):296–308.PubMedCrossRef

37.

Ramirez P, Sahuquillo JM, Cortes C, Kot P, Bonastre JM. Linezolid as rescue therapy for pneumococcal meningitis. Intensive Care Med 2007 May;33(5):924–5.PubMedCrossRef

38.

Lin TY, Chrane DF, Nelson JD, McCracken GH, Jr. Seven days of ceftriaxone therapy is as effective as ten days’ treatment for bacterial meningitis. JAMA 1985 Jun 28;253(24):3559–63.CrossRef

39.

Singhi P, Kaushal M, Singhi S, Ray P. Seven days vs. 10 days ceftriaxone therapy in bacterial meningitis. J Trop Pediatr 2002 Oct;48(5):273–9.PubMedCrossRef

40.

Briggs S, Ellis-Pegler R, Roberts S, Thomas M, Woodhouse A. Short course intravenous benzylpenicillin treatment of adults with meningococcal disease. Intern Med J 2004 Jul;34(7):383–7.PubMedCrossRef

41.

Ellis-Pegler R, Galler L, Roberts S, Thomas M, Woodhouse A. Three days of intravenous benzyl penicillin treatment of meningococcal disease in adults. Clin Infect Dis 2003 Sep 1;37(5):658–62.PubMedCrossRef

42.

de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002 Nov 14;347(20):1549–56.PubMedCrossRef

43.

Brouwer MC, McIntyre P, de Gans J, Prasad K, { ptvan de} Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2010 Sep 8;(9):CD004405.

44.

van de Beek D, de Gans J, McIntyre P, Prasad K. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2007 Jan 24;(1):CD004405.

45.

Heckenberg SG, Brouwer MC, ptvan der} Ende A, van de Beek D. Adjunctive dexamethasone in adults with meningococcal meningitis. Neurology 2012 Oct 9;79(15):1563–9.PubMedCrossRef

46.

Nguyen TH, Tran TH, Thwaites G, Ly VC, Dinh XS, Ho Dang TN, et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med 2007 Dec 13;357(24):2431–40.PubMedCrossRef

47.

Scarborough M, Gordon SB, Whitty CJ, French N, Njalale Y, Chitani A, et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med 2007 Dec 13;357(24):2441–50.PubMedCrossRef

48.

van de Beek D, Farrar JJ, de Gans J, Mai NT, Molyneux EM, Peltola H, et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol 2010 Mar;9(3):254–63.PubMedCentralPubMedCrossRef

49.

Molyneux EM, Walsh AL, Forsyth H, Tembo M, Mwenechanya J, Kayira K, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 2002 Jul;360(9328):211–8.PubMedCrossRef

50.

Molyneux EM, Kawaza K, Phiri A, Chimalizeni Y, Mankhambo L, Schwalbe E, et al. Glycerol and Acetaminophen as Adjuvant Therapy Did Not Affect the Outcome of Bacterial Meningitis in Malawian Children. Pediatr Infect Dis J 2013 Oct 16.

51.

Ajdukiewicz KM, Cartwright KE, Scarborough M, Mwambene JB, Goodson P, Molyneux ME, et al. Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial. Lancet Infect Dis 2011 Apr;11(4):293–300.PubMedCentralPubMedCrossRef

52.

Mourvillier B, Tubach F, van de BD, Garot D, Pichon N, Georges H, et al. Induced hypothermia in severe bacterial meningitis: a randomized clinical trial. JAMA 2013 Nov 27;310(20):2174–83.PubMedCrossRef

53.

Ostergaard C, Konradsen HB, Samuelsson S. Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection. BMC Infect Dis 2005 Oct 27;5:93.CrossRef

54.

Lucas MJ, Brouwer MC, van der EA, van de BD. Endocarditis in Adults with Bacterial Meningitis. Circulation 2013 Apr 17.

55.

Weisfelt M, van de Beek D, Spanjaard L, Reitsma JB, de Gans J. Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol 2006 Feb;5(2):123–9.PubMedCrossRef

56.

Pfister HW, Feiden W, Einhaupl KM. Spectrum of complications during bacterial meningitis in adults. Results of a prospective clinical study. Arch Neurol 1993 Jun;50(6):575–81.PubMedCrossRef

57.

Kramer AH, Bleck TP. Neurocritical care of patients with central nervous system infections. Curr Infect Dis Rep 2007 Jul;9(4):308–14.PubMedCrossRef

58.

Paul R, Koedel U, Pfister HW. Reduction of intracranial pressure by nimodipine in experimental pneumococcal meningitis. Crit Care Med 2000 Jul;28(7):2552–6.PubMedCrossRef

59.

Hosoglu S, Ceviz A, Kemaloglu MS, Sari I, Inaloz S, Geyik MF, et al. Effects of nimodipine on the cerebrovascular and neuronal changes during pneumococcal meningitis in the rat. Acta Microbiol Immunol Hung 1997;44(3):271–9.PubMed

60.

Lucas MJ, Brouwer MC, van de BD. Delayed cerebral thrombosis in bacterial meningitis: a prospective cohort study. Intensive Care Med 2013 May;39(5):866–71.

61.

Klein M, Koedel U, Kastenbauer S, Pfister HW, van de Beek D, Schut ES, et al. Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis: past as prologue: delayed stroke as a parainfectious process of bacterial meningitis? Neurology 2010 Jul 13;75(2):193–4.PubMedCrossRef

62.

Schut ES, Brouwer MC, de GJ, Florquin S, Troost D, van de BD. Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis. Neurology 2009 Dec 8;73(23):1988–95.

63.

Mook-Kanamori BB, Fritz D, Brouwer MC, van der EA, van de BD. Intracerebral hemorrhages in adults with community associated bacterial meningitis in adults: should we reconsider anticoagulant therapy? PLoS ONE 2012;7(9):e45271.CrossRef

64.

Southwick FS. Septic thrombophlebitis of major dural venous sinuses. Curr Clin Top Infect Dis 1995;15:179–203.:179-203.PubMed

65.

Zoons E, Weisfelt M, de GJ, Spanjaard L, Koelman JH, Reitsma JB, et al. Seizures in adults with bacterial meningitis. Neurology 2008 May 27;70(22 Pt 2):2109–15.PubMedCrossRef

66.

RKI. Invasive Meningokokken-Erkrankungen. RKI Ratgeber Infektionskrankheiten - Merkblätter für Ärzte. {rs URL www.rki.de} 2009.

67.

RKI (Robert Koch Institut). Empfehlung und Begründung einer postexpositionellen Meningokokken-Impfung. Epidemiologisches Bulletin 31, 314-317. 1-8-2009.

68.

Hoek MR, Christensen H, Hellenbrand W, Stefanoff P, Howitz M, Stuart JM. Effectiveness of vaccinating household contacts in addition to chemoprophylaxis after a case of meningococcal disease: a systematic review. Epidemiol Infect 2008 Nov;136(11):1441–7.PubMedCentralPubMedCrossRef

69.

RKI (Robert Koch Institut). Stellungnahme der Ständigen Impfkommission (STIKO) am Robert Koch-Institut (RKI) zum Stand der Bewertung des neuen Meningokokken-BImpfstoffs Bexsero. Epidemiologisches Bulletin 49, 495-498. 2013.

70.

Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004 Dec 1;39(9):1267–84.PubMedCrossRef

71.

Lee DH, Palermo B, Chowdhury M. Successful treatment of methicillin-resistant staphylococcus aureus meningitis with daptomycin. Clin Infect Dis 2008 Aug 15;47(4):588–90.PubMedCrossRef

72.

Pankey GA, Sabath LD. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Grampositive bacterial infections. Clin Infect Dis 2004 Mar 15;38(6):864–70.PubMedCrossRef

73.

Mitja O, Pigrau C, Ruiz I, Vidal X, Almirante B, Planes AM, et al. Predictors of mortality and impact of aminoglycosides on outcome in listeriosis in a retrospective cohort study. J Antimicrob Chemother 2009 May 25.

74.

Maya-Villar R, Garcia-Cabrera E, Sulleiro-Igual E, Fernandez-Viladrich P, Fontanals-Aymerich D, Catalan-Alonso P, et al. Threeyear multicenter surveillance of community-acquired Listeria monocytogenes meningitis in adults. BMC Infect Dis 2010 Nov 11;10:324.CrossRef

Titel: Akute bakterielle Meningitis — Diagnostik und Therapie
Infektionserkrankungen in der Neurologie
verfasst von: PD Dr. med. Matthias Klein
Prof. Dr. med. Hans-Walter Klein
Publikationsdatum: 30.07.2014
Verlag: Urban & Vogel
Erschienen in: DNP – Die Neurologie & Psychiatrie / Ausgabe 7-8/2014
Print ISSN: 2731-8168
Elektronische ISSN: 2731-8176
DOI: https://doi.org/10.1007/s15202-014-0718-9

Neu in den Fachgebieten Neurologie und Psychiatrie

23.04.2024 | Demenz | Nachrichten

Springer Medizin

Akute bakterielle Meningitis — Diagnostik und Therapie

Infektionserkrankungen in der Neurologie

Zusammenfassung

Neu in den Fachgebieten Neurologie und Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7-8/2014

Schlafstörungen durch tiefe Hirnstimulation

Hautbiopsie weist Parkinson nach

Morbus Parkinson: Fluktuationen umgehend behandeln

Frühdiagnose von Parkinson liegt oft daneben

Schutzmechanismen gegen psychische Belastungen

Sitzungsanzahl, Zeitaufwand und Nadeln limitiert

Neu in den Fachgebieten Neurologie und Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein